Prognostic value of wingless-type proteins in non-small cell lung cancer patients: a meta-analysis
Authors:
- Written on behalf of the AME Lung Cancer Collaborative GroupWGWritten on behalf of the AME Lung Cancer Collaborative Group
- Masaru KatohMasaru Katoh
- Kevin PhanKPKevin Phan
- Tangfeng LvTLTangfeng Lv
- Yong SongYSYong Song
- 1 August 2016
- journal article
- research article
- Published by AME Publishing Company in Translational Lung Cancer Research
- Vol. 5 (4) , 436-442
Abstract
Background: Wingless-type protein (Wnt) signaling pathway plays a crucial role in the development of human malignancies, such as epithelial-to-mesenchymal transition (EMT) and the maintenance of cancer stem cells (CSCs). Several studies have shown that the expression levels of Wnt proteins, ligands of Wnt signaling pathway, are related to clinical outcomes of non-small cell lung cancer (NSCLC) patients. This meta-analysis aimed to assess the prognostic value of Wnts proteins in patients with NSCLC. Methods: A multiple electronic literature search was conducted to identify all articles referring to the prognostic value of Wnt proteins in patients of NSCLC up to July 2016. Eligible studies were included in a meta-analysis in order to summarize the extracted data in terms of pooled hazard ratios (HRs) and their 95% confidence intervals (95% CIs). Results: Ten studies published between 2005 and 2015 were eligible for this meta-analysis. The total number of patients included was 1,805. The combined HR for all eligible studies evaluating the overall survival (OS) of NSCLC patients with positive Wnt expression was 1.60 (95% CI: 1.39–1.84). The subgroup analysis showed both Wnt1 and Wnt5a are associated with clinical outcome of NSCLC patients. Conclusions: Overexpression of Wnt proteins, as well as Wnt1 or Wnt5a alone, was markedly associated with adverse OS in lung cancer patients, suggesting that Wnts may act as a prognostic marker among NSCLCs.Keywords
This publication has 37 references indexed in Scilit:
- Wnt3 gene expression promotes tumor progression in non-small cell lung cancerLung Cancer, 2012
- Aberrant Wnt1/β-Catenin Expression is an Independent Poor Prognostic Marker of Non-small Cell Lung Cancer After SurgeryJournal of Thoracic Oncology, 2011
- Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancerCritical Reviews in Oncology/Hematology, 2010
- Intratumoral Wnt1 expression affects survivin gene expression in non-small cell lung cancerInternational Journal of Oncology, 2010
- Wnt/β-catenin signaling regulates cancer stem cells in lung cancer A549 cellsBiochemical and Biophysical Research Communications, 2010
- Wnt1 overexpression promotes tumour progression in non-small cell lung cancerEuropean Journal of Cancer, 2008
- Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and SurvivorshipMayo Clinic Proceedings, 2008
- Practical methods for incorporating summary time-to-event data into meta-analysisTrials, 2007
- Wnt signaling in lung cancerCancer Letters, 2005
- Measuring inconsistency in meta-analysesBMJ, 2003